doxorubicin
Heart failure frequently develops in patients treated with       doxorubicin (Adriamycin), when they receive a cumulative dose greater than 500       mg/m2.
Heart failure frequently develops in  @OBJECT$   @PREDICAT$  with        @SUBJECT$  (Adriamycin), when they receive a cumulative dose greater than 500       mg/m2.